Ovarian cancer is one of the deadliest cancers affecting women. Around the world, thousands of women lose their lives to this disease every year because it is often discovered too late.
In the early stages, ovarian cancer usually causes few or no symptoms. Even when symptoms do appear, they are often vague, such as bloating, stomach discomfort, feeling full quickly, or needing to urinate more often.
These signs can easily be mistaken for less serious health problems. As a result, many women are not diagnosed until the cancer has already spread, making treatment much more difficult.
A new study has now uncovered an important clue about where the most aggressive form of ovarian cancer begins. The findings, published in Nature Communications, could eventually lead to earlier diagnosis, better screening tests, and new treatments that improve survival.
The research was led by Dr. Alexander Nikitin and his team at the College of Veterinary Medicine at Cornell University. The scientists focused on high-grade serous carcinoma, often called HGSC. This is the most common and most aggressive type of ovarian cancer. It is responsible for most deaths from ovarian cancer.
For many years, scientists believed that this cancer started inside the ovaries. More recent research has suggested that it actually begins in the fallopian tubes, which are the thin tubes that carry eggs from the ovaries to the uterus. However, researchers did not know exactly which cells first changed into cancer.
The new study provides a likely answer. The scientists discovered that a special group of cells in the fallopian tubes, called pre-ciliated tubal epithelial cells, are especially likely to become cancerous.
To understand why this matters, it helps to know how these cells develop. The lining of the fallopian tube contains stem cells, which can produce new cells. Some of these new cells eventually become ciliated cells.
These mature cells have tiny hair-like structures called cilia that help move eggs and fluids through the fallopian tubes. Before becoming fully mature, the cells pass through a temporary stage known as the pre-ciliated stage.
The researchers found that this short transition stage appears to be the point where cancer is most likely to begin.
To investigate further, the team used genetically engineered mice. They studied two important genes called TP53 and RB1. These genes normally protect the body by stopping damaged cells from growing out of control.
Because of this, they are often called tumor-suppressor genes. In most cases of high-grade serous carcinoma in humans, both of these genes have been damaged or switched off.
The scientists turned off the mouse versions of these genes, called Trp53 and Rb1, in different types of fallopian tube cells.
The results were surprising. When stem cells lost these protective genes, they did not become cancerous. Instead, the cells simply died. However, when the same genes were switched off in the pre-ciliated cells, those cells rapidly developed into high-grade serous carcinoma.
This finding suggests that pre-ciliated cells are the true starting point of this dangerous cancer.
The researchers also identified another important clue. They found that a gene called Krt5 was highly active in these vulnerable cells. When they switched off Trp53 and Rb1 specifically in Krt5-positive cells, the mice quickly developed cancer, providing even stronger evidence that these cells are responsible for starting the disease.
This discovery could have major benefits in the future. If doctors can identify these pre-ciliated cells before they become cancerous, it may be possible to detect ovarian cancer much earlier than is currently possible. Earlier diagnosis often means more treatment options and a much better chance of survival.
The findings may also help scientists develop new medicines. Because the process of forming cilia is already well understood, researchers may be able to create drugs that stop these transitional cells from changing into cancer cells. Scientists could also design better screening tests that look for markers such as Krt5 to identify women at higher risk before tumors develop.
Although this research was carried out in mice, the fallopian tubes of mice and humans share many important similarities. The researchers believe the findings are likely to apply to people as well, but more studies using human tissue are needed before the results can be used in hospitals.
The study offers new hope for women and their families. By identifying the exact cells where this aggressive cancer begins, scientists are one step closer to developing earlier detection methods, more targeted treatments, and personalized care for women who face a high risk of ovarian cancer.
While more research is still required, this discovery marks an important advance in the fight against one of the hardest cancers to diagnose and treat.
If you care about cancer, please read studies that artificial sweeteners are linked to higher cancer risk, and how drinking milk affects risks of heart disease and cancer.
For more health information, please see recent studies about the best time to take vitamins to prevent heart disease, and results showing vitamin D supplements strongly reduces cancer death.
Copyright © 2026 Knowridge Science Report. All rights reserved.
